amplicon sequencing or metagenomics?
What is the difference between the two main methods for studying the microbiome: amplicon sequencing and metagenomic sequencing. What kind of information does each of them provide? What are its advantages, disadvantages and biases?
One way I approach this is the way NCBI SRA characterizes these terms. Amplicon is classified as strategy in SRA and metagenomic is described as source.
Strategy in SRA or as described here https://www.ebi.ac.uk/ena/submit/reads-library-strategy "Amplicon sequencing: An assay in which a DNA or RNA input molecule amplified by PCR is sequenced."
metagenomic is classified as a source i.ie pertaining to the type of sample.
Overall amplicon sequencing is a type of method/assay which not_only but can_also be applied to a sample of type metagenomic.